Skip NavigationSkip to Content
Return Return to Search Results

Nucleic acid nanobiosystems for cancer theranostics: an overview of emerging trends and challenges

  1. Author:
    Rebolledo, Laura P
    Andrade, Luciana N S
    Bajgelman, Marcio C
    Banks, Lawrence
    Breakefield, Xandra O
    Dobrovolskaia, Marina A
    Dokholyan, Nikolay V
    Kimura, Edna T
    Villa, Luisa
    Zerbini, Luiz F
    Zucolotto, Valtencir
    Afonin, Kirill A
    Strauss, Bryan E
    Chammas, Roger
    de Freitas Saito, Renata

  2. Author Address

    1Chemistry and Nanoscale Science Program, Department of Chemistry, University of North Carolina at Charlotte, Charlotte, NC, USA. 2Center for Translational Research in Oncology (LIM/24), Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil. 3Comprehensive Center for Precision Oncology (C2PO), Universidade de Sao Paulo, São Paulo, Brazil. 4Brazilian Biosciences National Laboratory, Center for Research in Energy and Materials, São Paulo, Brazil. 5Faculty of Pharmaceutical Sciences, University of Campinas, Campinas, São Paulo, Brazil. 6Medical School, University of Campinas, São Paulo, Brazil. 7Tumour Virology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy. 8Molecular Neurogenetics Unit, Department of Neurology and Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Boston, MA, USA. 9Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, sponsored by the National Cancer Institute, Frederick Maryland, USA. 10Departments of Pharmacology, and Biochemistry & Molecular Biology, Penn State College of Medicine, Hershey, PA, USA. 11Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. 12Department of Radiology and Oncology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil. 13Department of Cancer Genomics, International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa. 14Integrative Biomedical Sciences Division, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. 15Nanomedicine and Nanotoxicology Group, São Carlos Institute of Physics, University of São Paulo, São Paulo, Brazil.
    1. Year: 2025
    2. Date: May 06
    3. Epub Date: 2025 05 06
  2. Journal: Nanomedicine (London, England)
    1. Pages: 1-18
  4. Type of Article: Review
  1. Abstract:

    Different cancers remain major global health challenges due to their diverse biological behaviors and significant treatment hurdles. The aging of populations and lifestyle factors increase cancer occurrence and place increasing pressure on healthcare systems. Despite continuous advancements, many cancers remain fatal due to late-stage diagnosis, tumor heterogeneity, and drug resistance, thus necessitating urgent development of innovative treatment solutions. Therapeutic nucleic acids, a new class of biological drugs, offer a promising approach to overcoming these challenges. The recent Nucleic Acids and Nanobiosystems in Cancer Theranostics (NANCT) conference brought together internationally recognized experts from 15 countries to discuss cutting-edge research, spanning from oncolytic viruses to anticancer RNA nanoparticles and other emerging nanotechnologies. This review captures key insights and developments, emphasizing the need for interdisciplinary translation of scientific advancements into clinical practice and shaping the future of personalized cancer treatments for improved therapeutic outcomes.

    See More

External Sources

  1. View Full Text
  2. DOI: 10.1080/17435889.2025.2501919
  3. PMID: 40326805

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel